ARROWHEAD PHARMACEUTICALS, INC. — Director's Dealing 2015

Mar 10, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ARROWHEAD RESEARCH CORP (ARWR)
CIK: 0000879407
Period of Report: 2015-03-06

Reporting Person: Lewis David L. (Chief Scientific Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-03-06	Stock Option	$7.75	A	100000	Acquired	2025-03-06	Common Stock (100000)	Direct

Footnotes

F1: Option vests and becomes exercisable over a four year period from date of grant.